Ronald Muhlenkamp
Muhlenkamp & Co
Muhlenkamp & Co Portfolio 13F
Ronald Muhlenkamp Holdings Activity
- Portfolio value:
- $270.35M≈ (+$22M≈)
- Previous value:
- $248.50M≈
- # of changes:
- 36
- New positions:
- 1
- Reported for:
- 31 Mar 2021 (Q1)
- Latest filing date:
- 18 Aug 2021
Muhlenkamp & Co has disclosed a total of 36 changes to the portfolio in the (2021 Q1) SEC report(s): increased the number of shares of 18, bought 1 totally new, decreased the number of shares of 12 and completely sold out 5 position(s).
What stocks did Ronald Muhlenkamp buy in 2021 Q1?
During 2021 Q1 Ronald Muhlenkamp has bought 19 securities out of which top 5 purchases (by % change to portfolio) were (RUSHA) Rush Enterprises A Inc (added shares +0.20%), (MSFT) Microsoft Corp (added shares +0.01%), (AAPL) Apple Inc (added shares +0.06%), (BRK-B) Berkshire Hathaway Inc (added shares +0.15%) and (UNH) UnitedHealth Group Incorporated (added shares +0.14%).
In the 2021 Q1 report(s) the following changes have been made to the top investments: (WCC) WESCO International Inc (reduced shares -0.08%), (RUSHA) Rush Enterprises A Inc (added shares +0.20%), (MCHP) Microchip Technology Inc (reduced shares -0.08%), (DOW) Dow Inc (reduced shares -3.47%) and (MCK) McKesson Corp (reduced shares -7.75%).
36 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Equity Commonwealth
|
new
|
+38,348
|
38,348
|
+0.37%
|
$26.39
|
|
0.37%
|
2021 Q1
|
≈ 0.25 years
|
|
|
|
Schlumberger NV
|
+73.00%
|
+130,966
|
310,376
|
+1.32%
|
$27.19
|
+80.99%($49.21)
|
3.12%
|
2020 Q4
|
≈ 0.50 years
|
|
|
|
Royal Gold Inc
|
+22.21%
|
+4,426
|
24,350
|
+0.19%
|
$113.43
|
+76.49%($200.19)
|
1.02%
|
2020 Q4
|
≈ 0.50 years
|
|
|
|
Franco-Nevada Corp
|
+20.07%
|
+3,485
|
20,853
|
+0.2%
|
$152.30
|
+40.59%($214.13)
|
1.17%
|
2020 Q4
|
≈ 0.50 years
|
|
|
|
Alerian MLP ETF
|
+8.83%
|
+22,744
|
280,436
|
+0.27%
|
$32.43
|
+69.09%($54.84)
|
3.36%
|
2018 Q1
|
≈ 2.75 years
|
|
|
|
Pfizer Inc
|
+2.70%
|
+640
|
24,379
|
+0.01%
|
$50.41
|
-50.53%($24.94)
|
0.45%
|
2013 Q2 or earlier
|
≈ 7.50+ years
|
|
|
|
Rush Enterprises B Inc
|
+0.72%
|
+48
|
6,742
|
+0%
|
$42.27
|
+87.24%($79.15)
|
0.11%
|
2020 Q3
|
≈ 0.75 years
|
|
|
|
Lockheed Martin Corp
|
+0.57%
|
+110
|
19,319
|
+0.01%
|
$361.61
|
+60.73%($581.22)
|
2.58%
|
2019 Q3
|
≈ 1.50 years
|
|
|
|
Westinghouse Air Brake Technologies Corp
|
+0.57%
|
+312
|
55,276
|
+0.01%
|
$88.48
|
+233.84%($295.39)
|
1.81%
|
2019 Q1
|
≈ 2.00 years
|
|
|
|
CVS Health Corp
|
+0.31%
|
+334
|
108,645
|
+0.01%
|
$86.47
|
+21.75%($105.28)
|
3.48%
|
2019 Q3
|
≈ 1.50 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.